Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | REGN2878-DM1 |
Synonyms | |
Therapy Description |
REGN2878-DM1 is an antibody-drug conjugate comprising an antibody targeting the Prolactin Receptor (PRLR) linked to DM1, which delivers the cytotoxic agent to PRLR-expressing tumor cells, potentially resulting in increased cell-cycle arrest and decreased tumor growth (PMID: 28377489). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
REGN2878-DM1 | REGN2878-DM1 is an antibody-drug conjugate comprising an antibody targeting the Prolactin Receptor (PRLR) linked to DM1, which delivers the cytotoxic agent to PRLR-expressing tumor cells, potentially resulting in increased cell-cycle arrest and decreased tumor growth (PMID: 28377489). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|